ZNF469 Activators
ZNF469 activators constitute a crucial ensemble of chemicals pivotal in regulating ZNF469 gene expression through direct or indirect means. Among these, compounds like Retinoic Acid stand out for their direct activation of ZNF469. By binding to regulatory regions, Retinoic Acid enhances transcription, exerting a direct influence on cellular processes associated with ZNF469. Conversely Trichostatin A, Sodium Butyrate, Valproic Acid, Vorinostat, Scriptaid, Panobinostat, and MS-275, operate indirectly by impeding histone deacetylation. This epigenetic modulation significantly amplifies ZNF469 gene expression, underscoring their pivotal roles in the intricate epigenetic orchestration of ZNF469-associated cellular responses.
Further expanding the repertoire, epigenetic modulators like Dimethyl Sulfoxide (DMSO), 5-Aza-2'-deoxycytidine, Nicotinamide, and Butyric Acid exert their influence on ZNF469 gene expression through DNA methylation or histone acetylation patterns. Take, for instance, DMSO, which indirectly activates ZNF469 by molding DNA methylation patterns, showcasing its specific role in the nuanced epigenetic control of ZNF469-associated cellular responses. Collectively, these chemicals illuminate the diverse regulatory mechanisms governing ZNF469 expression. They provide profound insights into the elaborate and interconnected epigenetic landscape that finely tunes ZNF469-mediated cellular functions. In summary, ZNF469 activators, whether acting directly like Retinoic Acid or indirectly likeother epigenetic modulators, intricately shape the expression patterns of ZNF469. This detailed understanding not only elucidates their roles in modulating ZNF469-associated cellular responses but also underscores the complexity of epigenetic regulation governing gene expression in the cellular milieu.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid, a vitamin A derivative, directly activates ZNF469 by binding to its regulatory regions. This interaction enhances ZNF469 transcription, illustrating its role as a direct modulator of the gene expression associated with ZNF469, influencing cellular processes. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate, a histone deacetylase inhibitor, indirectly activates ZNF469 by promoting histone hyperacetylation. This epigenetic modification enhances ZNF469 gene expression, showcasing the compound's role in the epigenetic regulation of ZNF469-associated cellular responses. | ||||||
Dimethyl Sulfoxide (DMSO) | 67-68-5 | sc-202581 sc-202581A sc-202581B | 100 ml 500 ml 4 L | $31.00 $117.00 $918.00 | 136 | |
Dimethyl Sulfoxide (DMSO) indirectly activates ZNF469 by influencing DNA methylation patterns. This epigenetic modulation enhances ZNF469 gene expression, highlighting DMSO's role as a modulator of ZNF469-associated cellular responses through the regulation of DNA methylation. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
An inhibitor of DNA methylation, 5-Aza-2'-deoxycytidine indirectly activates ZNF469 by demethylating its regulatory regions. This epigenetic modification enhances ZNF469 gene expression, underscoring the compound's role in the epigenetic regulation of ZNF469-associated cellular responses. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic Acid, a histone deacetylase inhibitor, indirectly activates ZNF469 by preventing histone deacetylation. This epigenetic modulation enhances ZNF469 gene expression, showcasing the compound's role in the epigenetic regulation of ZNF469-associated cellular responses. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
Nicotinamide, a form of vitamin B3, indirectly activates ZNF469 by influencing the NAD+-dependent signaling pathway. This modulation enhances ZNF469 gene expression, illustrating the compound's role in the regulation of ZNF469-associated cellular responses through NAD+-mediated pathways. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat, a histone deacetylase inhibitor, indirectly activates ZNF469 by preventing histone deacetylation. This epigenetic modulation enhances ZNF469 gene expression, highlighting the compound's role in the epigenetic regulation of ZNF469-associated cellular responses. | ||||||
Butyric acid | 107-92-6 | sc-214640 sc-214640A | 1 kg 10 kg | $64.00 $177.00 | ||
Butyric Acid, a short-chain fatty acid, indirectly activates ZNF469 by influencing histone acetylation patterns. This epigenetic modulation enhances ZNF469 gene expression, illustrating the compound's role in the epigenetic regulation of ZNF469-associated cellular responses through histone modifications. | ||||||
Scriptaid | 287383-59-9 | sc-202807 sc-202807A | 1 mg 5 mg | $64.00 $183.00 | 11 | |
Scriptaid, a histone deacetylase inhibitor, indirectly activates ZNF469 by preventing histone deacetylation. This epigenetic modulation enhances ZNF469 gene expression, emphasizing the compound's role in the epigenetic regulation of ZNF469-associated cellular responses. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
Panobinostat, a histone deacetylase inhibitor, indirectly activates ZNF469 by preventing histone deacetylation. This epigenetic modulation enhances ZNF469 gene expression, showcasing the compound's role in the epigenetic regulation of ZNF469-associated cellular responses. | ||||||